相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HFE inhibits type I IFNs signaling by targeting the SQSTM1-mediated MAVS autophagic degradation
Juan Liu et al.
AUTOPHAGY (2021)
Ferroptosis and its potential role in the physiopathology of Parkinson's Disease
Laura Mahoney-Sanchez et al.
PROGRESS IN NEUROBIOLOGY (2021)
Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway
Yu Li et al.
ONCOLOGY LETTERS (2020)
Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers
Ling F. Ye et al.
ACS CHEMICAL BIOLOGY (2020)
Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis
Naoya Yamada et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Jackson G. Egen et al.
IMMUNITY (2020)
Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis
Yingying Yu et al.
BLOOD (2020)
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Xuexian Fang et al.
CIRCULATION RESEARCH (2020)
Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
Shogo Amano et al.
BMC CANCER (2020)
Systematic Review of the Clinical Outcomes of Iron Reduction in Hereditary Hemochromatosis
Anil Prabhu et al.
HEPATOLOGY (2020)
Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?
Lesang Shen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Is the era of sorafenib over? A review of the literature
Guanghan Fan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit
Yilong Zou et al.
CELL CHEMICAL BIOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The development of the concept of ferroptosis
Tal Hirschhorn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
VSIG-3 as a ligand of VISTA inhibits human T-cell function
Jinghua Wang et al.
IMMUNOLOGY (2019)
Simultaneous T Cell Activation and Macrophage Polarization to Promote Potent Tumor Suppression by Iron Oxide-Embedded Large-Pore Mesoporous Organosilica Core-Shell Nanospheres
Lin Chen et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Mechanism of Iron Oxide-Induced Macrophage Activation: The Impact of Composition and the Underlying Signaling Pathway
Zhengying Gu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale et al.
CELL METABOLISM (2019)
TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages
Kritika Sudan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
Shabnam Shalapour et al.
IMMUNITY (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors
Khalil Choucair et al.
FUTURE ONCOLOGY (2019)
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang et al.
CANCER DISCOVERY (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells through the Modulation of ROS
Alessandro Salatino et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Seyed Mohammadali Dadfar et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers
Charles A. Kunos et al.
FRONTIERS IN ONCOLOGY (2019)
Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
Shehua Qian et al.
EPMA JOURNAL (2019)
Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma
Lijia Luo et al.
BIOMATERIALS (2019)
Iron as a Central Player and Promising Target in Cancer Progression
Michaela Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Ferritin: A potential serum marker for lymph node metastasis in head and neck squamous cell carcinoma
Zhangwei Hu et al.
ONCOLOGY LETTERS (2019)
Artificially Reprogrammed Macrophages as Tumor-Tropic Immunosuppression-Resistant Biologics to Realize Therapeutics Production and Immune Activation
Chu-Xin Li et al.
ADVANCED MATERIALS (2019)
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
Hai-Hong Zhou et al.
FRONTIERS IN ONCOLOGY (2019)
Tumor-associated macrophages: a short compendium
Hans Prenen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer
Lin-Lin Cao et al.
BIOMETALS (2018)
Significance of serum ferritin as a prognostic factor in advanced hepatobilia cancer patients treated with Korean medicine: a retrospective cohort study
Anna Song et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
CD163 Is Required for Protumoral Activation o Macrophages in Human and Murine Sarcoma
Daisuke Shiraishi et al.
CANCER RESEARCH (2018)
Immune suppression and reversal of the suppressive tumor microenvironment
Kanako Shimizu et al.
INTERNATIONAL IMMUNOLOGY (2018)
The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers
Sandrine Tury et al.
JOURNAL OF PATHOLOGY (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Knockdown of zinc transporter ZIPS expression inhibits neuroblastoma progression and metastasis in vitro
Zhengrong Mei et al.
MOLECULAR MEDICINE REPORTS (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Suppression of ferroportin expression by cadmium stimulates proliferation, EM, and migration in triple-negative breast cancer cells
Zhongguo Shan et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells
Stephanie E. A. Burnell et al.
SCIENTIFIC REPORTS (2018)
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Jipeng Guo et al.
CANCER RESEARCH AND TREATMENT (2018)
Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion
Mingzhi Han et al.
NEOPLASIA (2018)
Iron and Cancer
Suzy V. Torti et al.
ANNUAL REVIEW OF NUTRITION, VOL 38 (2018)
Dual role of macrophage in tumor immunity
Ryota Tamura et al.
IMMUNOTHERAPY (2018)
STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
Yuan-Yu Wu et al.
FRONTIERS IN PHYSIOLOGY (2018)
IFN gamma-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
Ryan S. Lane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Role of the hepcidin-ferroportin axis in pathogen-mediated intracellular iron sequestration in human phagocytic cells
Rodrigo Abreu et al.
BLOOD ADVANCES (2018)
Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
Driton Vela et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Characterization of Ferroptosis in Murine Models of Hemochromatosis
Hao Wang et al.
HEPATOLOGY (2017)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14
Ningning Zhao et al.
NUTRIENTS (2017)
Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer
Xijuan Wang et al.
Oncotarget (2017)
Iron Induces Anti-tumor Activity in Tumor-Associcated Macrophages
Milene Costa da Silva et al.
FRONTIERS IN IMMUNOLOGY (2017)
Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2?
Michaela Jung et al.
FRONTIERS IN IMMUNOLOGY (2017)
Hemojuvelin regulates the innate immune response to peritoneal bacterial infection in mice
Qian Wu et al.
CELL DISCOVERY (2017)
Leukocyte trafficking in tumor microenvironment
Annalisa Del Prete et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system
Alexandre Reuben et al.
IMMUNITY INFLAMMATION AND DISEASE (2017)
Regulation of the Iron Homeostatic Hormone Hepcidin
Veena Sangkhae et al.
ADVANCES IN NUTRITION (2017)
A Red Carpet for Iron Metabolism
Martina U. Muckenthaler et al.
CELL (2017)
Hepcidin and ferroportin expression in breast cancer tissue and serum and their relationship with anemia
X. Pan et al.
CURRENT ONCOLOGY (2016)
Immunosuppressive cells in tumor immune escape and metastasis
Yang Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency
Haifa H. Jabara et al.
NATURE GENETICS (2016)
Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation
Seung Min Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Local iron homeostasis in the breast ductal carcinoma microenvironment
Oriana Marques et al.
BMC CANCER (2016)
EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1
Biao Wang et al.
CANCER LETTERS (2016)
Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis
Xiang Xue et al.
CELL METABOLISM (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
The impact of hypoxia on tumor-associated macrophages
Anne-Theres Henze et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
Saeid Zanganeh et al.
NATURE NANOTECHNOLOGY (2016)
Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression
Christina Mertens et al.
PLOS ONE (2016)
Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine-1-phosphate promotes lymphangiogenesis and tumor metastasis
Michaela Jung et al.
SCIENCE SIGNALING (2016)
Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer
Sarah Knocke et al.
CELL REPORTS (2016)
Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer
Sookyung Lee et al.
JOURNAL OF CANCER (2016)
Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine-1-phosphate promotes lymphangiogenesis and tumor metastasis
Michaela Jung et al.
SCIENCE SIGNALING (2016)
Hepcidin: regulation of the master iron regulator
Gautam Rishi et al.
BIOSCIENCE REPORTS (2015)
Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer
Lia Tesfay et al.
CANCER RESEARCH (2015)
Macrophage iron homeostasis and polarization in the context of cancer
Michaela Jung et al.
IMMUNOBIOLOGY (2015)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
From mice to humans: developments in cancer immunoediting
Michele W. L. Teng et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Control of adaptive immunity by the innate immune system
Akiko Iwasaki et al.
NATURE IMMUNOLOGY (2015)
Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function
Liangyu Chen et al.
ONCOLOGY REPORTS (2015)
Evolution of the immune system in humans from infancy to old age
A. Katharina Simon et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Iron metabolism and iron supplementation in cancer patients
Heinz Ludwig et al.
WIENER KLINISCHE WOCHENSCHRIFT (2015)
Decreased expression of ferroportin in prostate cancer
Dong Xue et al.
ONCOLOGY LETTERS (2015)
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Goldie Y. L. Lui et al.
ONCOTARGET (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Iron Deficiency Impairs Intra-Hepatic Lymphocyte Mediated Immune Response
Eliano Bonaccorsi-Riani et al.
PLOS ONE (2015)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Disordered hepcidin-ferroportin signaling promotes breast cancer growth
Shuping Zhang et al.
CELLULAR SIGNALLING (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
The role of iron in brain ageing and neurodegenerative disorders
Roberta Ward et al.
LANCET NEUROLOGY (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Conditional Deletion of Ferritin H in Mice Reduces B and T Lymphocyte Populations
Liviu Vanoaica et al.
PLOS ONE (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage
Qian Chen et al.
THORACIC CANCER (2014)
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Scott J. Dixon et al.
ELIFE (2014)
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages
Ahmed A. Alkhateeb et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Iron and cancer: more ore to be mined
Suzy V. Torti et al.
NATURE REVIEWS CANCER (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Tracy R. Daniels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study
Joseph Chao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
ZIP8 Is an Iron and Zinc Transporter Whose Cell-surface Expression Is Up-regulated by Cellular Iron Loading
Chia-Yu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Role of ferritin alterations in human breast cancer cells
Svitlana I. Shpyleva et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
H Ferritin Gene Silencing in a Human Metastatic Melanoma Cell Line: A Proteomic Analysis
Maddalena Di Sanzo et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype
Gaetano Cairo et al.
TRENDS IN IMMUNOLOGY (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells
M. F. Macedo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Differential regulation of iron homeostasis during human macrophage polarized activation
Stefania Recalcati et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position-7007 of the FPN1 promoter
Samuele Marro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Hemochromatosis Gene (HFE) Mutations and Cancer Risk: Expanding the Clinical Manifestations of Hereditary Iron Overload
Silvia Fargion et al.
HEPATOLOGY (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Zandra K. Pinnix et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
C. M. Nutting et al.
ANNALS OF ONCOLOGY (2009)
Absence of functional Hfe protects mice from invasive Salmonella enterica Serovar Typhimurium infection via induction of lipocalin-2
Manfred Nairz et al.
BLOOD (2009)
The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
Junko H. Ohyashiki et al.
CANCER SCIENCE (2009)
Systemic Iron Homeostasis and the Iron-Responsive Element/Iron-Regulatory Protein (IRE/IRP) Regulatory Network
Martina U. Muckenthaler et al.
Annual Review of Nutrition (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Iron overload and immunity
Graca Porto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
A role for mammalian target of rapamycin in regulating T cell activation versus anergy
Yan Zheng et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumor-derived CD4(+) CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10
Nicolas Larmonier et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells
Juan P. Liuzzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The CD8+T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis:: An update of clinical and immunological data from 70 C282Y homozygous subjects
Eugenia Cruz et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis
KA O'Donnell et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells
Alessandro Poggi et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress
A Baldi et al.
CLINICAL CANCER RESEARCH (2005)
Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
R Setoguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Differential inhibition of inducible T cell cytokine secretion by potent iron chelators
S Leung et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Transferrin is required for early T-cell differentiation
MF Macedo et al.
IMMUNOLOGY (2004)
Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-β1
RH McIntire et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Transferrin receptor 1 is differentially required in lymphocyte development
RM Ned et al.
BLOOD (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients
G Fabio et al.
JOURNAL OF HEPATOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
分享论文
